Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Zhen-Wei Zhu

Synthesis and Antiproliferative Activities Against Hep-G2 of Salicylanide Derivatives: Potent Inhibitors of the Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase

Journal of Enzyme Inhibition and Medicinal Chemistry

English

Related publications

Association of Initial Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Treatment and EGFR Exon 19 Deletion With Frequency of the T790M Mutation in Non-Small Cell Lung Cancer Patients After Resistance to First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

OncoTargets and Therapy

Oncology

Pharmacology

2019

English

How Sensitive Are Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitors for Squamous Cell Carcinoma of the Lung Harboring EGFR Gene–Sensitive Mutations?

Journal of Thoracic Oncology

English

Impact of Epidermal Growth Factor Receptor Gene Expression Level on Clinical Outcomes in Epidermal Growth Factor Receptor Mutant Lung Adenocarcinoma Patients Taking First-Line Epidermal Growth Factor Receptor–tyrosine Kinase Inhibitors

English

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors vs Conventional Chemotherapy in Non–Small Cell Lung Cancer Harboring Wild-Type Epidermal Growth Factor Receptor

JAMA - Journal of the American Medical Association

Medicine

2014

English

Correction To: Epidermal Growth Factor Receptor (EGFR)–Tyrosine Kinase Inhibitors (TKIs) Combined With Chemotherapy Delay Brain Metastasis in Patients With EGFR‑Mutant Lung Adenocarcinoma

English

The Treatment of Metastatic Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors

2013

English

Synthesis, Anticancer and Apoptosis-Inducing Activities of Quinazoline–isatin Conjugates: Epidermal Growth Factor Receptor-Tyrosine Kinase Assay and Molecular Docking Studies

Journal of Enzyme Inhibition and Medicinal Chemistry

English

Synthesis and in Vitro Cytotoxicity of the 4-(Halogenoanilino)-6-Bromoquinazolines and Their 6-(4-Fluorophenyl) Substituted Derivatives as Potential Inhibitors of Epidermal Growth Factor Receptor Tyrosine Kinase

Pharmaceuticals

Molecular Medicine

Pharmaceutical Science

2017

English

Nucleotide Binding by the Epidermal Growth Factor Receptor Protein-Tyrosine Kinase

Journal of Biological Chemistry

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Zhen-Wei Zhu

Synthesis and Antiproliferative Activities Against Hep-G2 of Salicylanide Derivatives: Potent Inhibitors of the Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase

Related publications

Association of Initial Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Treatment and EGFR Exon 19 Deletion With Frequency of the T790M Mutation in Non-Small Cell Lung Cancer Patients After Resistance to First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

How Sensitive Are Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitors for Squamous Cell Carcinoma of the Lung Harboring EGFR Gene–Sensitive Mutations?

Impact of Epidermal Growth Factor Receptor Gene Expression Level on Clinical Outcomes in Epidermal Growth Factor Receptor Mutant Lung Adenocarcinoma Patients Taking First-Line Epidermal Growth Factor Receptor–tyrosine Kinase Inhibitors

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors vs Conventional Chemotherapy in Non–Small Cell Lung Cancer Harboring Wild-Type Epidermal Growth Factor Receptor

Correction To: Epidermal Growth Factor Receptor (EGFR)–Tyrosine Kinase Inhibitors (TKIs) Combined With Chemotherapy Delay Brain Metastasis in Patients With EGFR‑Mutant Lung Adenocarcinoma

The Treatment of Metastatic Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors

Synthesis, Anticancer and Apoptosis-Inducing Activities of Quinazoline–isatin Conjugates: Epidermal Growth Factor Receptor-Tyrosine Kinase Assay and Molecular Docking Studies

Synthesis and in Vitro Cytotoxicity of the 4-(Halogenoanilino)-6-Bromoquinazolines and Their 6-(4-Fluorophenyl) Substituted Derivatives as Potential Inhibitors of Epidermal Growth Factor Receptor Tyrosine Kinase

Nucleotide Binding by the Epidermal Growth Factor Receptor Protein-Tyrosine Kinase